Reply to: "Inhibitory effects of colchicine on inflammasomes"

Atherosclerosis. 2018 Jun:273:155-156. doi: 10.1016/j.atherosclerosis.2018.03.042. Epub 2018 Mar 28.

Authors

Gonzalo J Martínez¹, David S Celermajer², Sanjay Patel²

Affiliations

¹ Division of Cardiovascular Diseases, Pontificia Universidad Católica, Santiago, Chile. Electronic address: gjmartin@uc.cl.
² Department of Cardiology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney and Heart Research Institute, Sydney, New South Wales, Australia.

PMID: 29628279
DOI: 10.1016/j.atherosclerosis.2018.03.042

No abstract available

Keywords: Atherosclerosis; Colchicine; IL-1beta; NLRP3 inflammasome.

Publication types

Letter
Comment

MeSH terms

Atherosclerosis*
Colchicine
Humans
Inflammasomes*
Inflammation
NLR Family, Pyrin Domain-Containing 3 Protein

Substances

Inflammasomes
NLR Family, Pyrin Domain-Containing 3 Protein
NLRP3 protein, human
Colchicine